Clinical Trials Logo

Filter by:
NCT ID: NCT06000735 Not yet recruiting - Stress Clinical Trials

Daily Blood Glucose Trends in Patients at Risk for Diabetes

Start date: October 1, 2023
Phase: N/A
Study type: Interventional

The goal of this study is to learn about the relationship between blood sugar, diet, stress, and metabolic parameters including waist circumference, body mass index (BMI), cholesterol levels and blood pressure in patients at risk for diabetes. The main questions it aims to answer are 1) are there trends in blood sugar responses after meals for patients at risk of developing diabetes? And 2) are there correlations between stress and fluctuations in blood sugar? During the first visit, participant's waist circumference, body composition, cholesterol, and resting blood pressure will be measured, and a continuous glucose monitor sensor will be placed on the participant's non-dominant arm. This sensor will be worn for seven days, and the participant will be asked to complete a daily food log during that time. Each participant will be asked to return to clinic after one week to return the continuous glucose monitor and daily food log.

NCT ID: NCT06000696 Active, not recruiting - COPD Clinical Trials

Healthy at Home Pilot

Start date: September 9, 2022
Phase:
Study type: Observational [Patient Registry]

The objective is to conduct a pilot-feasibility trial of the "Healthy at Home" program, a multimodal intervention aimed at preventing acute care needs among COPD patients. The program will feature a digital platform and virtual pulmonary rehabilitation to facilitate complex care management of UMass Memorial Health Patients

NCT ID: NCT06000683 Recruiting - Lung Cancer Clinical Trials

Empowering Patients' Lung Cancer Screening Uptake

Empower-LCS
Start date: October 13, 2023
Phase: N/A
Study type: Interventional

Lung cancer is the leading cause of cancer related mortality. Lung cancer screening (LCS) with low dose computed tomography (LDCT) decreases mortality rate of lung cancer by 20%. Yet many patients who are eligible for lung cancer screening are still falling through the cracks which prevents patients the ability to detect lung cancer early. This study will test the effect of a a multi-level intervention on ordering LDCT within 6 months after patient enrollment. Our proposed intervention includes (1) Primary care provider notifications of patients' LCS eligibility; (2) patients' education ; (3) patients' referral to financial navigation resources; and (4) patients' reminder to discuss LCS during PCP visit.

NCT ID: NCT06000592 Recruiting - Clinical trials for Spinal Cord Injuries

Safety, Feasibility, and Efficacy of TSCS on Stabilizing Blood Pressure for Acute Inpatients With SCI

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

Current forms of pharmacologic and non-pharmacologic treatments for hypotension and orthostatic hypotension (OH) remain inadequate during acute inpatient rehabilitation (AIR) following a traumatic spinal cord injury (SCI). A critical need exists for the identification of safe, practical, and effective treatment options that stabilize blood pressure (BP) after traumatic SCI. Recent published evidence suggests that transcutaneous Spinal Cord Stimulation (TSCS) can be used to raise seated BP, and mitigate the falls in BP during orthostatic repositioning in individuals with chronic SCI. This site-specific project will focus on the use of TSCS to stabilizing seated BP and mitigate the fall in BP during orthostatic repositioning during AIR following traumatic SCI.

NCT ID: NCT06000540 Not yet recruiting - Clinical trials for Coronary Artery Disease

Needle Free Assessment of Myocardial Oxygenation in Healthy Subjects

NIMO-Healthy
Start date: June 15, 2024
Phase: N/A
Study type: Interventional

This is a prospective pilot study to evaluate the safety, tolerability and efficacy of utilizing precise computer controlled gas challenge in healthy subjects for identification of coronary artery disease.

NCT ID: NCT06000501 Recruiting - Clinical trials for Adult Attention Deficit Hyperactivity Disorder

Duration and Efficacy of Azstarys on Adult ADHD Symptoms and Executive Function in Early Evening

Start date: September 14, 2023
Phase: Phase 4
Study type: Interventional

This is a single-site study. One purpose of this trial is to extend the safety and efficacy evidence basis for Azstarys in adults with ADHD. This open-label, treatment study will examine the efficacy of Azstarys on ADHD symptoms using the AISRS 18-item total score on the AISRS-expanded; the Adult ADHD Investigator Symptom Rating Scale. The investigators will also examine Executive Function later in the day (early evening, about 12 hours after first morning dosing).

NCT ID: NCT06000488 Not yet recruiting - Burn Out Clinical Trials

Trial to Evaluate the Efficacy of a Manualized Reflective Writing Program for Clinical Phase Physician Assistant (PA) Students.

Start date: January 2024
Phase: N/A
Study type: Interventional

The following will be an open label controlled efficacy trial of the effects of longitudinal participation in an existing reflective writing program for medical students on burnout in physician assistant students.

NCT ID: NCT06000475 Not yet recruiting - Clinical trials for Stress Disorders, Post-Traumatic

Enhancing Memory in CPT for PTSD

Start date: July 1, 2024
Phase: N/A
Study type: Interventional

Several psychotherapies for posttraumatic stress disorder (PTSD) have a strong evidence base for their efficacy, but nonresponse rates are high, particularly among older Veterans. Accumulating evidence indicates that memory deficits and poor learning of therapy contents adversely affect psychotherapy treatment response in PTSD. However, limited research has examined methods for increasing learning of therapy contents in psychotherapy for PTSD. The proposed study aims to examine the feasibility of integrating an intervention to increase learning and memory of psychotherapy content into the provision of a widely used psychotherapy, cognitive processing therapy (CPT), for older adults with PTSD. The ultimate goal of this line of research is to develop novel rehabilitation interventions to increase functioning for individuals with PTSD.

NCT ID: NCT06000423 Recruiting - Bleeding Clinical Trials

Tranexamic Acid to Reduce Contraceptive-related Bleeding Side Effects

Start date: January 23, 2024
Phase: Phase 4
Study type: Interventional

This randomized double blinded trial seeks to determine whether tranexamic acid (TXA) is an efficacious treatment for contraceptive induced menstrual changes (CIMC) including irregular, bothersome bleeding caused by the etonogestrel subdermal contraceptive implant (ENG implant). Participants will be randomized into the TXA treatment arm or a placebo. They will begin taking the medication after three consecutive days of bleeding. Participants will track their bleeding using an automated text message service

NCT ID: NCT06000410 Recruiting - Knee Osteoarthritis Clinical Trials

A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee

Start date: September 6, 2023
Phase: Phase 3
Study type: Interventional

This study is being conducted to evaluate the efficacy and safety of ASA compared to placebo in the management of osteoarthritis (OA) symptoms of the knee.